UPDATE: Cowen Upgrades Takeda Pharmaceutical (TAK) to Outperform
Tweet Send to a Friend
(Updated - July 19, 2022 5:30 AM EDT)
Cowen analyst Ken Cacciatore upgraded Takeda Pharmaceutical (NYSE: TAK) from Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen analyst Ken Cacciatore upgraded Takeda Pharmaceutical (NYSE: TAK) from Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
